Device Trial Radar · NCT05549232
Hypoxic Red Blood Cells for Burns and Hematological Malignancies at Haukeland University Hospital
Last checked: Nov 20, 2026Latest source record: Jul 23, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
22
Actual
Start
Aug 24, 2022
Primary completion
May 16, 2024
Study completion May 16, 2024
Sponsor
- Lead sponsor
- HemanextNot on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 22, 2022
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The overall objective of this study is to collect preliminary safety data on the transfusion of hypoxic RBCs, manufactured with the Hemanext ONE device, in patients with burns and patients with hematological malignancies. The Hemanext ONE device received CE mark in April 2021.
Conditions
- Hematologic Neoplasms
- Burns
Interventions
Hypoxic Red Blood CellsDevice
Hypoxic Red Blood Cells manufactured with the Hemanext ONE device- CPD/PAGGSM Red Blood Cells, Leukocytes Reduced, and O2/CO2 Reduced
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants Who Experienced an Adverse Event (All Types/Grades) Within a Time Frame up to 24 Hours Following the Transfusion.Time frame: 24 hours
- Number of Participants Who Experienced an Adverse Event (AE) (All Types/Grades) Overall up to 7 Days (+/-1 Day) After the Transfusion.Time frame: 7 days (+/-1 day)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Haukeland University Hospital
Bergen, Norway
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.